Nifty
Sensex
:
:
13055.15
44523.02
128.70 (1.00%)
445.87 (1.01%)

Pharmaceuticals & Drugs - Global

Rating :
50/99  (View)

BSE: 532872 | NSE: SPARC

179.80
6.00 (3.45%)
24-Nov-2020 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  174.45
  •  181.50
  •  169.65
  •  173.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2051394
  •  3688.41
  •  210.90
  •  81.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,550.45
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,618.34
  • N/A
  • -100.14

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.46%
  • 5.74%
  • 17.77%
  • FII
  • DII
  • Others
  • 2.91%
  • 0.01%
  • 5.11%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.79
  • -13.79
  • -0.62

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 46.89
  • 37.45
  • 5.03

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 43.39
  • 34.88
  • 16.61

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -10.87
  • -10.87
  • -10.87

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.88
  • -37.18
  • -30.44

Quarterly Results

Standalone Figures in Rs. Crores

Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0
0
0
0
0
0
0
0
0
0
0
0
EBITDA
0
0
0
0
0
0
0
0
0
0
0
0
EBIDTM
0%
0%
0%
0%
0%
0%
0%
0%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
0
0
0
0
0
0
0
0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
PAT
0
0
0
0
0
0
0
0
0
0
0
0
PATM
0%
0%
0%
0%
0%
0%
0%
0%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update


  • Sun Pharma Advanced Research’s net loss widens to Rs 83 crore in Q2
    10th Nov 2020, 11:57 AM

    Total income of the company increased 5.19% at Rs 20.46 crore for Q2FY21

    Read More
  • Sun Pharma Advanced reports positive top-line results for investigational drug ‘SDN-037’
    14th Oct 2020, 11:02 AM

    The objective of the trial was to assess the efficacy and safety of SDN-037 in clearing the inflammation and pain

    Read More
  • SPARC grants exclusive license to Tripoint Therapeutics LLC, USA
    22nd Sep 2020, 09:38 AM

    The company will be eligible to receive tiered royalties ranging from 15% to 50% on net sales

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.